- Filed
- Feb 9, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2021 · Jan 31, 2021 | 285.06M sh |
| Stock Repurchased | Q1 2021 · Dec 31, 2020 | $0 |
| Stock Repurchased | Q1 2021 · Dec 31, 2019 | $92.44M |
| Long Term Debt | Q1 2021 · Dec 31, 2020 | $1.55B |
| Long Term Debt | Q1 2021 · Sep 30, 2020 | $1.54B |
| Short Term Debt | Q1 2021 · Dec 31, 2020 | $1.05B |
| Short Term Debt | Q1 2021 · Sep 30, 2020 | $432.21M |
| Current Liabilities | Q1 2021 · Dec 31, 2020 | $1.6B |
| Current Liabilities | Q1 2021 · Sep 30, 2020 | $986.14M |
| Total Liabilities | Q1 2021 · Dec 31, 2020 | $2.44B |
| Total Liabilities | Q1 2021 · Sep 30, 2020 | $2.45B |
| Current Assets | Q1 2021 · Dec 31, 2020 | $784.2M |
| Current Assets | Q1 2021 · Sep 30, 2020 | $735.99M |
| Total Assets | Q1 2021 · Dec 31, 2020 | $3.65B |
| Total Assets | Q1 2021 · Sep 30, 2020 | $3.59B |
| Shares Diluted | Q1 2021 · Dec 31, 2019 | 289.45M sh |
| Capex | Q1 2021 · Dec 31, 2019 | $14.2M |
| Operating Cash Flow | Q1 2021 · Dec 31, 2019 | $53.55M |
| Cash And Equivalents | Q1 2021 · Dec 31, 2019 | $301.46M |
| Cash And Equivalents restated | Q1 2021 · Sep 30, 2018 | $560.96M |
| Eps Diluted | Q1 2021 · Dec 31, 2019 | $0.17 |
| Eps Basic | Q1 2021 · Dec 31, 2019 | $0.17 |
| Sga Expense restated | Q1 2021 · Dec 31, 2019 | $38.33M |
| Net Income | Q1 2021 · Dec 31, 2019 | $48.69M |
| Operating Income restated | Q1 2021 · Dec 31, 2019 | $36M |
| Gross Profit restated | Q1 2021 · Dec 31, 2019 | $211.8M |
| Cost Of Revenue restated | Q1 2021 · Dec 31, 2019 | $149.71M |
| Revenue restated | Q1 2021 · Dec 31, 2019 | $361.51M |